The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical executive search for their development leadership team. The expectation of an accelerated time frame for completion resulted in the successful placement of Claire Blanchette as Vice President, Compound Development Team Lead. Reporting directly to the EVP & Chief Development Officer, Blanchette’s well-rounded background will be crucial to oversee the solid tumors program, providing visionary leadership to team members. Blanchette’s role is instrumental in developing a highly effective international project team and supporting future expansion. It is a privilege to partner with Genmab and aid in their organizational growth as they strive to create and develop innovative products with the aim of improving the lives of cancer patients. The Chase Group never loses sight of how its services can profoundly impact the future success of an organization and appreciate a focused collaboration with Genmab. To learn how The Chase Group can identify high caliber talent for your team, please contact email@example.com.
- Categories: Life Sciences, Pharmaceutical
- Client: Genmab